GROSSMAN D KEITH 4
4 · Outset Medical, Inc. · Filed Jun 3, 2024
Insider Transaction Report
Form 4
GROSSMAN D KEITH
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-06-03−38,117→ 0 totalExercise: $1.11Exp: 2024-06-16→ Common Stock (38,117 underlying) - Exercise/Conversion
Common Stock
2024-06-03$1.11/sh+38,117$42,310→ 85,922 total - Sale
Common Stock
2024-06-03$3.74/sh−11,887$44,468→ 74,035 total - Sale
Common Stock
2024-06-03$3.80/sh−26,230$99,766→ 47,805 total - Exercise/Conversion
Common Stock
2024-06-03$1.11/sh+31,186$34,616→ 74,035 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-06-03−31,186→ 38,117 totalExercise: $1.11Exp: 2024-06-16→ Common Stock (31,186 underlying)
Holdings
- 5,186(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $3.66-$3.83. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This option vested 25% on April 15, 2015 and then in 36 equal monthly installments thereafter.